作者的详细信息

Balakhonova, T V

期 栏目 标题 文件
卷 80, 编号 7 (2008) Editorial Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis
卷 81, 编号 6 (2009) Editorial Affection of target organs in hypertensive patients with and without metabolic syndrome
卷 81, 编号 9 (2009) Editorial Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment
卷 83, 编号 8 (2011) Editorial Prolongation of enoxaparin therapy to one month promotes recanalization of occlusively thrombosed deep veins
卷 83, 编号 9 (2011) Editorial Relationship between a concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of arterial wall in patients with low and moderate risk by SCORE scale
卷 83, 编号 12 (2011) Editorial Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications
卷 84, 编号 9 (2012) Editorial Nonspecific inflammation and structural changes in the arteries of hypertensive males at high and moderate risk for cardiovascular events
卷 84, 编号 9 (2012) Editorial Trends in the risk factors and signs of subclinical atherosclerosis in subjects at low and moderate risk according to the SCORE scale in different medical management tactics: Two-year follow-up results
卷 91, 编号 9 (2019) Editorial Comparative efficacy and safety of enoxaparin followed by warfarin and rivaroxaban monotherapy in the treatment of venous thrombosis in patients after intracardiac catheter interventions PDF
(Rus)

##common.cookie##